Showing papers by "Leelavinothan Pari published in 2015"

Protective effects of hesperidin on oxidative stress, dyslipidaemia and histological changes in iron-induced hepatic and renal toxicity in rats.

Abstract: The present study was to evaluate the protective role of hesperidin (HDN) against iron-induced hepatic and renal toxicity in rats. Administration of iron (30 mg/kg body weight) intraperitoneally for 10 days, the levels of serum hepatic markers, renal functional markers, lipid profile, lipid peroxidation markers and iron concentration in blood were significantly (p < 0.05) increased. The toxic effect of iron was also indicated by significant (p < 0.05) decrease in the levels of plasma, liver and kidney of enzymatic and non-enzymatic antioxidants. Administration of hesperidin at different doses (20, 40 and 80 mg/kg body weight) significantly (p < 0.05) reversed the levels of serum hepatic markers, renal functional markers, lipid profile, lipid peroxidation markers, restored the levels of hepatic, renal enzymatic antioxidants and non-enzymatic antioxidants with decrease in iron concentration in blood. Hesperidin at a dose of 80 mg/kg body weight exhibits significant protection on hepatic and renal when compared with other two doses (20 and 40 mg/kg body weight). All these changes were corroborating by histological observations of liver and kidney. This study demonstrated the protective role of hesperidin in reducing toxic effects of iron in experimental rats.

Antihyperglycemic effect of trans-anethole in streptozotocin induced diabetic rats with special reference to glycoprotein components

Abstract: Objective: To evaluate the antidiabetic effect of trans-anethole, a natural terpenoid on the levels of glycoprotein components in plasma and tissues of streptozotocin induced diabetic rats. Methods: Diabetes was induced in male albino Wistar rats by a single intraperitoneal injection of streptozotocin (40 mg/kg b.w). Trans-anethole was administered orally at a dose of (80 mg/kg b.w) for 45 days. The effect of trans-anethole was studied on plasma glucose, insulin, plasma and tissue glycoproteins. Results: Oral administration of trans-anethole (80 mg/kg b.w) for 45 days modulated the altered levels of plasma and tissue glycoprotein components to near normal. No significant changes were observed in normal rats treated with trans-anethole. Conclusion: The present findings suggest that trans-anethole possesses a protective effect on altered glycoprotein metabolism in addition to its antihyperglycemic activity.